+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Anthelmintic Drugs Market - Global Forecast 2026-2032- Product Image
Anthelmintic Drugs Market - Global Forecast 2026-2032- Product Image
Sale

Anthelmintic Drugs Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • July 2026
  • Region: Global
  • 360iResearch™
  • ID: 5206457
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Anthelmintic Drugs Market is projected to reach USD 4.17 Billion in 2026. It is expected to continue growing at a CAGR of 8.28%, reaching USD 6.74 Billion by 2032.

Anthelmintic drugs are essential anti-parasitic medicines used to prevent and treat helminth infections caused by nematodes, cestodes, and trematodes in humans and animals. Their role spans public health, livestock productivity, companion animal care, and food security, particularly in regions where soil-transmitted helminths, schistosomiasis, lymphatic filariasis, and gastrointestinal worm burdens remain persistent. Demand dynamics are shaped by national deworming programs, veterinary parasite-control protocols, antimicrobial and antiparasitic stewardship, rising companion animal ownership, and the need to protect agricultural output from productivity losses linked to parasitic infection. The landscape is also influenced by drug-resistance surveillance, combination therapy research, improved diagnostics, and policies supporting preventive chemotherapy in endemic populations. As governments, healthcare providers, veterinarians, and animal health stakeholders prioritize integrated parasite management, anthelmintic drugs continue to occupy a strategic position across human medicine, veterinary medicine, and One Health initiatives.

Transformative Shifts in the Anthelmintic Drugs Landscape

The anthelmintic drugs landscape is undergoing a shift from routine treatment models toward evidence-guided parasite control. In human health, mass drug administration programs continue to support disease control in endemic settings, while stronger pharmacovigilance and monitoring are improving treatment quality and safety. In animal health, livestock producers are increasingly adopting targeted selective treatment, fecal egg count monitoring, pasture management, and rotational strategies to reduce unnecessary exposure and slow resistance development. Regulatory authorities are strengthening quality standards for antiparasitic medicines, and procurement systems are placing greater emphasis on reliable supply, affordability, and program continuity. Innovation is also moving beyond conventional formulations toward improved palatability, fixed-dose combinations, extended-release delivery, and species-specific dosing formats. These transformative shifts are aligning anthelmintic use with precision health, sustainability, and long-term parasite-resistance management.

Cumulative Impact of Artificial Intelligence on Anthelmintic Drugs

Artificial intelligence is becoming a practical enabler across the anthelmintic drugs value chain, particularly in drug discovery, resistance monitoring, pharmacovigilance, and supply optimization. AI-supported molecular screening can help identify promising antiparasitic compounds and repurposing opportunities by analyzing biological pathways, parasite genomics, and structure-activity relationships. In field applications, machine learning models can support risk mapping for helminth transmission by combining climate, sanitation, livestock movement, land use, and treatment-history data. AI-enabled image analysis is also improving the efficiency of parasite egg detection in fecal diagnostics, supporting more targeted treatment decisions in veterinary and human health settings. Across supply chains, predictive analytics can help public health agencies and animal health distributors reduce stockouts, optimize inventory placement, and align procurement with seasonal parasite pressure. While AI does not replace laboratory validation or clinical evidence, it strengthens decision-making and accelerates the movement toward data-driven parasite control.

Key Regional Insights for Anthelmintic Drugs

Asia-Pacific remains a high-priority region for anthelmintic drugs due to a large population base, extensive livestock production, tropical and subtropical transmission conditions, and ongoing public health programs targeting soil-transmitted helminths and other neglected tropical diseases. Countries across the region combine school-based deworming, veterinary parasite management, and aquaculture-related health monitoring with improving diagnostic capacity. North America is characterized by strong companion animal care, advanced veterinary diagnostics, regulated livestock production, and high emphasis on parasite prevention protocols, with treatment decisions increasingly supported by surveillance and stewardship practices. Latin America faces diverse helminth burdens linked to rural livelihoods, climate variability, and livestock systems, while public and veterinary health efforts focus on access, education, and integrated parasite management. Europe shows strong regulatory oversight, established veterinary prescribing practices, and rising attention to anthelmintic resistance, especially in grazing livestock and equine health. The Middle East presents a mixed profile shaped by livestock trade, arid and semi-arid environments, migrant workforce health needs, and expanding veterinary infrastructure. Africa carries a substantial burden of helminth-related disease in both humans and animals, making access to quality-assured anthelmintics, mass treatment campaigns, sanitation improvements, and livestock productivity programs central to regional priorities.

Key Group Insights for Anthelmintic Drugs

ASEAN countries are important to the anthelmintic drugs landscape because tropical climate patterns, dense rural populations, smallholder farming, and public deworming initiatives support sustained attention to helminth control across both human and animal health. The GCC region emphasizes regulated healthcare delivery, livestock import management, camel and small-ruminant health, and preventive veterinary services, with parasite control linked to biosecurity and food supply resilience. The European Union reflects a mature regulatory and stewardship environment where veterinary antiparasitic use is shaped by prescribing controls, residue limits, environmental considerations, and growing resistance surveillance. BRICS economies combine large populations, major livestock sectors, and varying burdens of endemic parasitic disease, creating strong policy relevance for affordable medicines, domestic production capacity, and public health treatment programs. G7 countries generally show advanced research infrastructure, high veterinary care standards, and strong quality assurance, with emphasis on diagnostics, evidence-based prescribing, and innovation in human and animal antiparasitic therapies. NATO member countries overlap significantly with advanced healthcare and veterinary systems, where medical readiness, food supply security, zoonotic risk management, and resilient pharmaceutical supply chains contribute to the strategic relevance of anthelmintic access and oversight.

Key Country Insights for Anthelmintic Drugs

The United States demonstrates strong demand for anthelmintic drugs across companion animal care, livestock production, equine health, and regulated public health channels, with emphasis on prescription oversight, parasite diagnostics, and resistance-aware treatment. Canada reflects similar priorities, supported by veterinary stewardship, livestock health management, and companion animal preventive care, while Mexico combines companion animal growth, livestock needs, and public health relevance in rural and peri-urban settings. Brazil is a major animal health environment where cattle, sheep, companion animals, and tropical parasite pressures make integrated parasite control important, while the United Kingdom, Germany, France, Italy, and Spain are shaped by stringent regulatory systems, established veterinary services, grazing livestock management, and increasing concern over responsible anthelmintic use. Russia’s large geography, livestock base, and varied climatic zones create broad parasite-control needs across animal health and public health contexts. China and India are central to global anthelmintic relevance due to large populations, significant livestock sectors, ongoing deworming initiatives, and expanding pharmaceutical manufacturing and healthcare access. Japan and South Korea show advanced veterinary care, regulated pharmaceutical quality, and strong companion animal health adoption, while Australia places particular emphasis on livestock parasite resistance management, grazing systems, and evidence-based worm control strategies.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize resistance stewardship by supporting diagnostics-led treatment, fecal egg count monitoring, and education on appropriate dosing and rotation strategies. Investment in quality-assured manufacturing, stable supply chains, and pharmacovigilance is essential to maintain trust across public health and veterinary channels. Product development should focus on improved adherence through palatable formulations, fixed-dose combinations where clinically appropriate, weight-appropriate dosing, and delivery formats suitable for field conditions. Stakeholders should strengthen collaboration with public health agencies, veterinarians, livestock producers, and academic institutions to improve surveillance for anthelmintic resistance and treatment outcomes. Digital tools, including AI-enabled risk mapping and diagnostic support, should be adopted carefully with validation against field data. Organizations should also align with One Health principles by considering human health, animal health, environmental exposure, and food security together when designing parasite-control strategies.

Research Methodology

This executive summary is developed through a structured secondary research approach using verified and publicly available sources, including public health guidelines, regulatory frameworks, veterinary medicine references, disease-control program documentation, peer-reviewed scientific literature, and recognized One Health and neglected tropical disease resources. The analysis synthesizes evidence on helminth disease burden, anthelmintic use patterns, resistance concerns, veterinary applications, regulatory priorities, regional health infrastructure, and technology adoption. Insights are cross-validated across human health, animal health, and agricultural contexts to avoid reliance on a single data stream. The methodology excludes market sizing, revenue estimation, share calculation, and forecasting, focusing instead on qualitative, evidence-backed interpretation of structural drivers, policy relevance, regional dynamics, and operational priorities in the anthelmintic drugs landscape.

Conclusion

Anthelmintic drugs remain indispensable to global health, veterinary care, livestock productivity, and food security. The sector is evolving through stronger stewardship, better diagnostics, improved formulations, resistance monitoring, and the gradual integration of artificial intelligence into discovery, surveillance, and supply planning. Regional needs vary considerably, from mass deworming and access priorities in endemic settings to diagnostics-led prescribing and resistance management in mature veterinary systems. Future progress will depend on responsible use, quality assurance, collaborative surveillance, and One Health coordination that connects human medicine, animal health, agriculture, and environmental protection. Organizations that combine scientific rigor with practical field implementation will be best positioned to support sustainable parasite control and long-term treatment effectiveness.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Anthelmintic Drugs Market, by Drug Class
7.1. Introduction
7.2. Benzimidazoles
7.3. Imidazothiazoles And Tetrahydropyrimidines
7.4. Macrocyclic Lactones
8. Anthelmintic Drugs Market, by Animal Type
8.1. Introduction
8.2. Companion Animals
8.2.1. Cats
8.2.2. Dogs
8.3. Food Producing Animals
8.3.1. Cattle
8.3.2. Poultry
8.3.3. Sheep And Goat
8.3.4. Swine
8.4. Human
8.4.1. Adults
8.4.2. Pediatric
9. Anthelmintic Drugs Market, by Route Of Administration
9.1. Introduction
9.2. Oral
9.3. Parenteral
9.4. Topical
10. Anthelmintic Drugs Market, by Sales Channel
10.1. Introduction
10.2. Online
10.3. Offline
11. Anthelmintic Drugs Market, by Application
11.1. Introduction
11.2. Human Health
11.3. Veterinary Health
11.4. Poultry
11.5. Aquaculture
12. Anthelmintic Drugs Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Anthelmintic Drugs Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Anthelmintic Drugs Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Aden Healthcare
16.2. Anikem Laboratories
16.3. Bayer AG
16.4. Boehringer Ingelheim International GmbH
16.5. Ceva Sante Animale
16.6. Cipla Limited
16.7. Dechra Pharmaceuticals PLC
16.8. Dr.Reddys Laboratories Inc.
16.9. Edenbridge Pharmaceuticals LLC
16.10. GlaxoSmithKline PLC
16.11. Green Cross Remedies
16.12. Healthy Life Pharma Private Limited
16.13. Johnson & Johnson Services, Inc.
16.14. Kosher Pharmaceuticals
16.15. Lineage Therapeutics Inc
16.16. Lupin Limited
16.17. Mankind Pharma Ltd.
16.18. McKesson Corporation
16.19. Merck & Co., Inc.
16.20. Norbrook Laboratories Limited
16.21. Novartis AG
16.22. Sankur Pharmaceuticals Pvt. Ltd
16.23. Takeda Pharmaceutical Company Limited
16.24. Virbac S.A.
16.25. Weefsel Pharma
List of Figures
FIGURE 1. GLOBAL ANTHELMINTIC DRUGS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ANTHELMINTIC DRUGS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL ANTHELMINTIC DRUGS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL ANTHELMINTIC DRUGS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025 VS 2032 (%)
FIGURE 7. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2025 VS 2032 (%)
FIGURE 13. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL ANTHELMINTIC DRUGS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL ANTHELMINTIC DRUGS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL ANTHELMINTIC DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BENZIMIDAZOLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BENZIMIDAZOLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BENZIMIDAZOLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL IMIDAZOTHIAZOLES AND TETRAHYDROPYRIMIDINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL IMIDAZOTHIAZOLES AND TETRAHYDROPYRIMIDINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL IMIDAZOTHIAZOLES AND TETRAHYDROPYRIMIDINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL MACROCYCLIC LACTONES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL MACROCYCLIC LACTONES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL MACROCYCLIC LACTONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DOGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL DOGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL FOOD PRODUCING ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL FOOD PRODUCING ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL FOOD PRODUCING ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL POULTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL SHEEP AND GOAT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL SHEEP AND GOAT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL SHEEP AND GOAT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL SWINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL SWINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL HUMAN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL HUMAN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL HUMAN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ADULTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ADULTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ADULTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ORAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ORAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL PARENTERAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL PARENTERAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL PARENTERAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL HUMAN HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL HUMAN HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL HUMAN HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL VETERINARY HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL VETERINARY HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL VETERINARY HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL POULTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL AQUACULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL AQUACULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL AQUACULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 80. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 81. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 82. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY FOOD PRODUCING ANIMALS, 2018-2032 (USD MILLION)
TABLE 83. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2032 (USD MILLION)
TABLE 84. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 85. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 86. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 87. NORTH AMERICA ANTHELMINTIC DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA ANTHELMINTIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA ANTHELMINTIC DRUGS MARKET SIZE, BY FOOD PRODUCING ANIMALS, 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA ANTHELMINTIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA ANTHELMINTIC DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. LATIN AMERICA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA ANTHELMINTIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 100. LATIN AMERICA ANTHELMINTIC DRUGS MARKET SIZE, BY FOOD PRODUCING ANIMALS, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA ANTHELMINTIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 105. EUROPE ANTHELMINTIC DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. EUROPE ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 107. EUROPE ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 108. EUROPE ANTHELMINTIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 109. EUROPE ANTHELMINTIC DRUGS MARKET SIZE, BY FOOD PRODUCING ANIMALS, 2018-2032 (USD MILLION)
TABLE 110. EUROPE ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2032 (USD MILLION)
TABLE 111. EUROPE ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 112. EUROPE ANTHELMINTIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 113. EUROPE ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 114. MIDDLE EAST ANTHELMINTIC DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. MIDDLE EAST ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST ANTHELMINTIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 118. MIDDLE EAST ANTHELMINTIC DRUGS MARKET SIZE, BY FOOD PRODUCING ANIMALS, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2032 (USD MILLION)
TABLE 120. MIDDLE EAST ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 121. MIDDLE EAST ANTHELMINTIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 122. MIDDLE EAST ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 123. AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 125. AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 126. AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 127. AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY FOOD PRODUCING ANIMALS, 2018-2032 (USD MILLION)
TABLE 128. AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2032 (USD MILLION)
TABLE 129. AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 130. AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 131. AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. ASEAN ANTHELMINTIC DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 134. ASEAN ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 135. ASEAN ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 136. ASEAN ANTHELMINTIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 137. ASEAN ANTHELMINTIC DRUGS MARKET SIZE, BY FOOD PRODUCING ANIMALS, 2018-2032 (USD MILLION)
TABLE 138. ASEAN ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2032 (USD MILLION)
TABLE 139. ASEAN ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 140. ASEAN ANTHELMINTIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 141. ASEAN ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 142. GCC ANTHELMINTIC DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 143. GCC ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 144. GCC ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 145. GCC ANTHELMINTIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 146. GCC ANTHELMINTIC DRUGS MARKET SIZE, BY FOOD PRODUCING ANIMALS, 2018-2032 (USD MILLION)
TABLE 147. GCC ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2032 (USD MILLION)
TABLE 148. GCC ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 149. GCC ANTHELMINTIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 150. GCC ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION ANTHELMINTIC DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 153. EUROPEAN UNION ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION ANTHELMINTIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION ANTHELMINTIC DRUGS MARKET SIZE, BY FOOD PRODUCING ANIMALS, 2018-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2032 (USD MILLION)
TABLE 157. EUROPEAN UNION ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION ANTHELMINTIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 159. EUROPEAN UNION ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 160. BRICS ANTHELMINTIC DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 161. BRICS ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 162. BRICS ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 163. BRICS ANTHELMINTIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 164. BRICS ANTHELMINTIC DRUGS MARKET SIZE, BY FOOD PRODUCING ANIMALS, 2018-2032 (USD MILLION)
TABLE 165. BRICS ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2032 (USD MILLION)
TABLE 166. BRICS ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 167. BRICS ANTHELMINTIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 168. BRICS ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 169. G7 ANTHELMINTIC DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 170. G7 ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 171. G7 ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 172. G7 ANTHELMINTIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 173. G7 ANTHELMINTIC DRUGS MARKET SIZE, BY FOOD PRODUCING ANIMALS, 2018-2032 (USD MILLION)
TABLE 174. G7 ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2032 (USD MILLION)
TABLE 175. G7 ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 176. G7 ANTHELMINTIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 177. G7 ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 178. NATO ANTHELMINTIC DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 179. NATO ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 180. NATO ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 181. NATO ANTHELMINTIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 182. NATO ANTHELMINTIC DRUGS MARKET SIZE, BY FOOD PRODUCING ANIMALS, 2018-2032 (USD MILLION)
TABLE 183. NATO ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2032 (USD MILLION)
TABLE 184. NATO ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 185. NATO ANTHELMINTIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 186. NATO ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 188. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 189. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 190. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 191. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 192. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY FOOD PRODUCING ANIMALS, 2018-2032 (USD MILLION)
TABLE 193. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2032 (USD MILLION)
TABLE 194. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 195. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 196. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 197. CANADA ANTHELMINTIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 198. CANADA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 199. CANADA ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 200. CANADA ANTHELMINTIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 201. CANADA ANTHELMINTIC DRUGS MARKET SIZE, BY FOOD PRODUCING ANIMALS, 2018-2032 (USD MILLION)
TABLE 202. CANADA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2032 (USD MILLION)
TABLE 203. CANADA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 204. CANADA ANTHELMINTIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 205. CANADA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 206. MEXICO ANTHELMINTIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 207. MEXICO ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 208. MEXICO ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 209. MEXICO ANTHELMINTIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 210. MEXICO ANTHELMINTIC DRUGS MARKET SIZE, BY FOOD PRODUCING ANIMALS, 2018-2032 (USD MILLION)
TABLE 211. MEXICO ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2032 (USD MILLION)
TABLE 212. MEXICO ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 213. MEXICO ANTHELMINTIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 214. MEXICO ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 215. BRAZIL ANTHELMINTIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 216. BRAZIL ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 217. BRAZIL ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 218. BRAZIL ANTHELMINTIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 219. BRAZIL ANTHELMINTIC DRUGS MARKET SIZE, BY FOOD PRODUCING ANIMALS, 2018-2032 (USD MILLION)
TABLE 220. BRAZIL ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2032 (USD MILLION)
TABLE 221. BRAZIL ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 222. BRAZIL ANTHELMINTIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 223. BRAZIL ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 224. UNITED KINGDOM ANTHELMINTIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 225. UNITED KINGDOM ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 226. UNITED KINGDOM ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 227. UNITED KINGDOM ANTHELMINTIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 228. UNITED KINGDOM ANTHELMINTIC DRUGS MARKET SIZE, BY FOOD PRODUCING ANIMALS, 2018-2032 (USD MILLION)
TABLE 229. UNITED KINGDOM ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2032 (USD MILLION)
TABLE 230. UNITED KINGDOM ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 231. UNITED KINGDOM ANTHELMINTIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 232. UNITED KINGDOM ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 233. GERMANY ANTHELMINTIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 234. GERMANY ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 235. GERMANY ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 236. GERMANY ANTHELMINTIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 237. GERMANY ANTHELMINTIC DRUGS MARKET SIZE, BY FOOD PRODUCING ANIMALS, 2018-2032 (USD MILLION)
TABLE 238. GERMANY ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2032 (USD MILLION)
TABLE 239. GERMANY ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 240. GERMANY ANTHELMINTIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 241. GERMANY ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 242. FRANCE ANTHELMINTIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 243. FRANCE ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 244. FRANCE ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 245. FRANCE ANTHELMINTIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 246. FRANCE ANTHELMINTIC DRUGS MARKET SIZE, BY FOOD PRODUCING ANIMALS, 2018-2032 (USD MILLION)
TABLE 247. FRANCE ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2032 (USD MILLION)
TABLE 248. FRANCE ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 249. FRANCE ANTHELMINTIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 250. FRANCE ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 251. RUSSIA ANTHELMINTIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 252. RUSSIA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 253. RUSSIA ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 254. RUSSIA ANTHELMINTIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 255. RUSSIA ANTHELMINTIC DRUGS MARKET SIZE, BY FOOD PRODUCING ANIMALS, 2018-2032 (USD MILLION)
TABLE 256. RUSSIA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2032 (USD MILLION)
TABLE 257. RUSSIA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 258. RUSSIA ANTHELMINTIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 259. RUSSIA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 260. ITALY ANTHELMINTIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 261. ITALY ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 262. ITALY ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 263. ITALY ANTHELMINTIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 264. ITALY ANTHELMINTIC DRUGS MARKET SIZE, BY FOOD PRODUCING ANIMALS, 2018-2032 (USD MILLION)
TABLE 265. ITALY ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2032 (USD MILLION)
TABLE 266. ITALY ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 267. ITALY ANTHELMINTIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 268. ITALY ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 269. SPAIN ANTHELMINTIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 270. SPAIN ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 271. SPAIN ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 272. SPAIN ANTHELMINTIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 273. SPAIN ANTHELMINTIC DRUGS MARKET SIZE, BY FOOD PRODUCING ANIMALS, 2018-2032 (USD MILLION)
TABLE 274. SPAIN ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2032 (USD MILLION)
TABLE 275. SPAIN ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 276. SPAIN ANTHELMINTIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 277. SPAIN ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 278. CHINA ANTHELMINTIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 279. CHINA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 280. CHINA ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 281. CHINA ANTHELMINTIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 282. CHINA ANTHELMINTIC DRUGS MARKET SIZE, BY FOOD PRODUCING ANIMALS, 2018-2032 (USD MILLION)
TABLE 283. CHINA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2032 (USD MILLION)
TABLE 284. CHINA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 285. CHINA ANTHELMINTIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 286. CHINA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 287. INDIA ANTHELMINTIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 288. INDIA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 289. INDIA ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 290. INDIA ANTHELMINTIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 291. INDIA ANTHELMINTIC DRUGS MARKET SIZE, BY FOOD PRODUCING ANIMALS, 2018-2032 (USD MILLION)
TABLE 292. INDIA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2032 (USD MILLION)
TABLE 293. INDIA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 294. INDIA ANTHELMINTIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 295. INDIA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 296. JAPAN ANTHELMINTIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 297. JAPAN ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 298. JAPAN ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 299. JAPAN ANTHELMINTIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 300. JAPAN ANTHELMINTIC DRUGS MARKET SIZE, BY FOOD PRODUCING ANIMALS, 2018-2032 (USD MILLION)
TABLE 301. JAPAN ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2032 (USD MILLION)
TABLE 302. JAPAN ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 303. JAPAN ANTHELMINTIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 304. JAPAN ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 305. AUSTRALIA ANTHELMINTIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 306. AUSTRALIA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 307. AUSTRALIA ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 308. AUSTRALIA ANTHELMINTIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 309. AUSTRALIA ANTHELMINTIC DRUGS MARKET SIZE, BY FOOD PRODUCING ANIMALS, 2018-2032 (USD MILLION)
TABLE 310. AUSTRALIA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2032 (USD MILLION)
TABLE 311. AUSTRALIA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 312. AUSTRALIA ANTHELMINTIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 313. AUSTRALIA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 314. SOUTH KOREA ANTHELMINTIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 315. SOUTH KOREA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 316. SOUTH KOREA ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 317. SOUTH KOREA ANTHELMINTIC DRUGS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
TABLE 318. SOUTH KOREA ANTHELMINTIC DRUGS MARKET SIZE, BY FOOD PRODUCING ANIMALS, 2018-2032 (USD MILLION)
TABLE 319. SOUTH KOREA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2032 (USD MILLION)
TABLE 320. SOUTH KOREA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 321. SOUTH KOREA ANTHELMINTIC DRUGS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 322. SOUTH KOREA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 323. GLOBAL ANTHELMINTIC DRUGS MARKET SHARE, BY KEY PLAYER, 2025
TABLE 324. GLOBAL ANTHELMINTIC DRUGS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • Aden Healthcare
  • Anikem Laboratories
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Cipla Limited
  • Dechra Pharmaceuticals PLC
  • Dr.Reddys Laboratories Inc.
  • Edenbridge Pharmaceuticals LLC
  • GlaxoSmithKline PLC
  • Green Cross Remedies
  • Healthy Life Pharma Private Limited
  • Johnson & Johnson Services, Inc.
  • Kosher Pharmaceuticals
  • Lineage Therapeutics Inc
  • Lupin Limited
  • Mankind Pharma Ltd.
  • McKesson Corporation
  • Merck & Co., Inc.
  • Norbrook Laboratories Limited
  • Novartis AG
  • Sankur Pharmaceuticals Pvt. Ltd
  • Takeda Pharmaceutical Company Limited
  • Virbac S.A.
  • Weefsel Pharma

Table Information

Report AttributeDetails
No. of Pages197
PublishedJuly 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 4.17 Billion
Forecasted Market Value ( USD ) by 2032 $ 6.74 Billion
Compound Annual Growth Rate8.2%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Anthelmintic Drugs Market Report 2026 - Product Image

Anthelmintic Drugs Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Parasitic Diseases Therapeutics - Global Strategic Business Report - Product Image

Parasitic Diseases Therapeutics - Global Strategic Business Report

  • Report
  • 279 Pages
  • Global
From
Neglected Tropical Diseases Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035) - Product Image

Neglected Tropical Diseases Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035)

  • Report
  • 400 Pages
  • Global
From
Antiparasitic Drugs Market Report 2026 - Product Image

Antiparasitic Drugs Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Albendazole Veterinary - Global Strategic Business Report - Product Image

Albendazole Veterinary - Global Strategic Business Report

  • Report
  • 383 Pages
  • Global
From

About the Anthelmintic Market

Anthelmintic drugs are used to treat parasitic worm infections, such as roundworm, hookworm, and whipworm. These drugs are used to treat a variety of conditions, including gastrointestinal, respiratory, and skin infections. Anthelmintic drugs work by killing the worms or preventing them from reproducing. They can also be used to prevent reinfection. Anthelmintic drugs are part of the larger market of infectious disease drugs, which includes antibiotics, antivirals, and antifungals. These drugs are used to treat a wide range of infectious diseases, from common colds to more serious conditions such as HIV/AIDS. The anthelmintic market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Merck & Co., Pfizer, GlaxoSmithKline, Sanofi, Bayer, and Novartis. These companies offer a range of products, from generic drugs to more specialized treatments. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.